143 related articles for article (PubMed ID: 21918885)
1. Loss of Bad expression confers poor prognosis in non-small cell lung cancer.
Huang Y; Liu D; Chen B; Zeng J; Wang L; Zhang S; Mo X; Li W
Med Oncol; 2012 Sep; 29(3):1648-55. PubMed ID: 21918885
[TBL] [Abstract][Full Text] [Related]
2. The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.
Yu Y; Zhong Z; Guan Y
Int J Clin Exp Pathol; 2015; 8(10):13075-82. PubMed ID: 26722503
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
5. LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.
Liu Y; Xing Y; Wang H; Yan S; Wang X; Cai L
Thorac Cancer; 2018 Dec; 9(12):1725-1732. PubMed ID: 30273983
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer.
Qiu ZX; Wang L; Han J; Liu D; Huang W; Altaf K; Qiu XS; Javed MA; Zheng J; Chen BJ; Li WM
Cancer Sci; 2012 Oct; 103(10):1774-9. PubMed ID: 22738312
[TBL] [Abstract][Full Text] [Related]
7. Activating enhancer-binding protein-2β nucleolar localization predicts poor survival after stage I non-small cell lung cancer resection.
Kim MP; Chen Y; Bekele BN; Lopez A; Khanna A; Chen JQ; Spitz MR; Behrens C; Solis L; Wismach M; Ji L; Wistuba II; Roth JA; Katz RL
Ann Thorac Surg; 2011 Sep; 92(3):1044-50. PubMed ID: 21871297
[TBL] [Abstract][Full Text] [Related]
8. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
9. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of ERCC1, RRM1, BRCA1 and SETDB1 in early stage of non-small cell lung cancer.
Lafuente-Sanchis A; Zúñiga Á; Galbis JM; Cremades A; Estors M; Martínez-Hernández NJ; Carretero J
Clin Transl Oncol; 2016 Aug; 18(8):798-804. PubMed ID: 26542178
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of Psoriasin for non-small cell lung cancer patients and its biological impact on lung cancer cell functions.
Hu M; Ye L; Ruge F; Zhi X; Zhang L; Jiang WG
BMC Cancer; 2012 Dec; 12():588. PubMed ID: 23228205
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival.
Zhou J; Bi H; Zhan P; Chang C; Xu C; Huang X; Yu L; Yao X; Yan J
Tumour Biol; 2014 Oct; 35(10):9777-85. PubMed ID: 24981246
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
[TBL] [Abstract][Full Text] [Related]
16. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
[TBL] [Abstract][Full Text] [Related]
17. CIP2A with survivin protein expressions in human non-small-cell lung cancer correlates with prognosis.
Xu P; Xu XL; Huang Q; Zhang ZH; Zhang YB
Med Oncol; 2012 Sep; 29(3):1643-7. PubMed ID: 21874565
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.
Miao S; Qiu T; Zhao Y; Wang H; Sun X; Wang Y; Xuan Y; Qin Y; Jiao W
Thorac Cancer; 2018 Sep; 9(9):1136-1144. PubMed ID: 30047626
[TBL] [Abstract][Full Text] [Related]
19. Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer.
Yu Y; Wang Z; Zhang MY; Liu XY; Zhang H
Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):166-9. PubMed ID: 20935042
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC).
Tang Z; Shen Q; Xie H; Zhou X; Li J; Feng J; Liu H; Wang W; Zhang S; Ni S
Oncotarget; 2016 Jul; 7(29):46253-46262. PubMed ID: 27323829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]